- €15.01m
- €11.92m
- €73.91m
- 57
- 95
- 41
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 68.2 | 50.7 | 52.3 | 55.8 | 73.9 |
Cost of Revenue | |||||
Gross Profit | 23.6 | 18.6 | 20.4 | 20.2 | 24.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 66.5 | 52.2 | 51.2 | 54.7 | 70.8 |
Operating Profit | 1.69 | -1.42 | 1.11 | 1.14 | 3.14 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.65 | -1.43 | 1.74 | 1.07 | 2.97 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.22 | -1.28 | 1.25 | 0.72 | 2.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.22 | -1.28 | 1.25 | 0.72 | 2.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.22 | -1.28 | 1.25 | 0.72 | 2.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 32 | -29.4 | 22.4 | 17.3 | 33.2 |
Dividends per Share |